Rabeprazole
Back to searchMolecule Structure
Scientific Name
Rabeprazole
Description of the Drug
Rabeprazole is a proton pump inhibitor used to help gastrointestinal ulcers heal, to treat symptoms of gastroesophageal reflux disease (GERD), to eradicate Helicobacter pylori, and to treat hypersecretory conditions such as Zollinger-Ellison Syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01129
http://www.drugbank.ca/drugs/DB01129
Brand Name(s)
Not Available
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Alkem Laboratories Ltd, Rubicon Research Private Ltd, Aurobindo Pharma Ltd, Amneal Pharmaceuticals, Dr Reddys Laboratories Ltd, Mylan Pharmaceuticals Inc, Lannett Co Inc, Aytu Bioscience Inc, Torrent Pharmaceuticals Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Potassium-transporting ATPase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2095173 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL23336 | ||
| PharmGKB | PA451216 | ||
| Human Metabolome Database | HMDB0005026 | ||
| DrugBank | DB01129 | ||
| PubChem: Thomson Pharma | 14828218 | ||
| PubChem | 5029 | ||
| Mcule | MCULE-7848941080 | ||
| LINCS | LSM-5045 | ||
| Nikkaji | J395.966J | ||
| EPA CompTox Dashboard | DTXSID3044122 | ||
| DrugCentral | 2350 | ||
| Brenda | 14573 | ||
| ChemicalBook | CB3680731 | ||
| Guide to Pharmacology | 7290 | ||
| rxnorm | RABEPRAZOLE | ACIPHEX | RABEPRAZOLE SODIUM |
| KEGG Ligand | C07864 | ||
| ChEBI | 8768 |
